跳至主要内容
临床试验/TCTR20210529001
TCTR20210529001尚未招募4 期

Efficacy and applicability of topical cannabidiol-based treatment in psoriasis patient, randomized, placebo, controlled trial

Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital0 个研究点目标入组 30 人开始时间: 2021年5月29日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. male/female 18-70 years 2. plaque type psoriasis, mild severity 3.able to comply with study protocol 4. willingly inform consent

排除标准

  • 1. unable to stop previous treatment (washout period; systemic treatment 4 weeks, topical treatment 2 weeks). 2. abnormal liver or renal function 3. psychological disorder 4. Pregnant or lactating women 5. allergic to study product.

研究者

发起方
Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital

相似试验